Regulatory
October 7, 2025
Regulatory
September 19, 2025
Positive 16-week Phase 3 Data of Izokibep in Hidradenitis Suppurativa Presented at EADV 2025
Regulatory
September 11, 2025
Regulatory
June 13, 2025
Affibody Medical Investor Relations
Regulatory
October 7, 2025
Regulatory
September 19, 2025
Positive 16-week Phase 3 Data of Izokibep in Hidradenitis Suppurativa Presented at EADV 2025
Regulatory
September 11, 2025
Regulatory
June 13, 2025